Document Detail


Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies.
MedLine Citation:
PMID:  16482446     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fungal infections represent a life-threatening complication for patients receiving chemotherapy or undergoing hematopoietic stem cell transplantation. Historically, antifungal monotherapy is associated with a poor outcome. We treated three children with hematological malignancies and proven fungal infections (one cerebral mold infection, one disseminated Candida infection, one naso-pharyngeal mucor infection) with combination antifungal therapy plus granulocyte-colony-stimulation-factor-mobilized granulocyte transfusions as secondary prophylaxis during subsequent neutropenic episodes. With this approach, the fungal infection was effectively treated, and the anticancer therapy was completed without major delay. All children survived the fungal infection and the underlying malignancy. These experiences illustrate the feasibility of this approach using more than one antifungal agent together with immune-therapy in high-risk patients.
Authors:
Lorenz Grigull; Andreas Beilken; Hansjoerg Schmid; P Kirschner; Karl-Walter Sykora; Christin Linderkamp; Frank Donnerstag; Lilia Goudeva; Hans-Gert Heuft; Karl Welte
Related Documents :
15134326 - Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
10492666 - Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. a pan...
17652486 - First case of bloodstream infection due to candida magnoliae in a chinese oncological p...
16110346 - Posaconazole.
23210636 - Borrelia miyamotoi infections among wild rodents show age and month independence and co...
12117966 - Sat, the secreted autotransporter toxin of uropathogenic escherichia coli, is a vacuola...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2006-02-16
Journal Detail:
Title:  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer     Volume:  14     ISSN:  0941-4355     ISO Abbreviation:  Support Care Cancer     Publication Date:  2006 Jul 
Date Detail:
Created Date:  2006-06-14     Completed Date:  2006-12-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9302957     Medline TA:  Support Care Cancer     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  783-6     Citation Subset:  IM    
Affiliation:
Department of Paediatric Haematology and Oncology, Medizinische Hochschule Hannover, OE 6780, Carl-Neuberg Str. 1, D-30625 Hannover, Germany. Grigull.Lorenz@mh-hannover.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Antifungal Agents / therapeutic use*
Aspergillosis / prevention & control
Candidiasis / prevention & control
Child, Preschool
Combined Modality Therapy
Feasibility Studies
Female
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocytes*
Hematologic Neoplasms / drug therapy,  therapy*
Hematopoietic Stem Cell Transplantation / adverse effects
Humans
Leukocyte Transfusion*
Male
Mucormycosis / prevention & control
Mycoses / etiology,  prevention & control*
Myelodysplastic Syndromes / therapy
Neutropenia / complications,  etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Chemical
Reg. No./Substance:
0/Antifungal Agents; 143011-72-7/Granulocyte Colony-Stimulating Factor
Comments/Corrections
Comment In:
Support Care Cancer. 2007 Feb;15(2):233-4; author reply 235   [PMID:  17036226 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cancer patients' preferences for communication of unfavourable news: an Asian perspective.
Next Document:  Advocacy skills training for young adult cancer survivors: the Young Adult Survivors Conference at C...